Related Experiment Video
Updated: Jul 4, 2026

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis
Michael Zeisberg1, Raghu Kalluri
1Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. mzeisber@bidmc.harvard.edu
Abstract:
Our current understanding of epithelial-mesenchymal transition (EMT) in the setting of tissue fibrosis is largely based on pioneering studies in the kidney. Evidence is emerging that EMT is a key component of chronic kidney disease, contributing to both destruction of the tubular epithelial compartment and accumulation of interstitial fibroblasts. While knowledge regarding EMT was previously based on experimental rodent studies, in recent years the evolving evidence demonstrates a role for EMT in human kidney diseases with chronic fibrosis.
Related Concept Videos
Introduction to Fibroblasts
Cirrhosis II: Pathophysiology
Chronic Kidney Disease I: Introduction
Chronic Inflammation: Introduction

